DUBLIN, Ireland - (Business Wire) Research and Markets (
http://www.researchandmarkets.com/research/e90995/directory_of_top_6) has announced the addition of the "Directory of Top 60 Biopharmaceutical Manufacturers in China" directory to their offering.
The first edition of the China Biopharmaceutical Index includes the Top 60 Biopharmaceutical Companies in China, with detailed profiles of their business focus, products, revenues, R&D and business strategies, international objectives, partnering strategies, and marketing activities. In addition, subscribers will receive on-going updates to activities and trends in China as the country’s biopharmaceutical industry expands. Our China Biopharmaceutical Index and our Top 60 Directory provide you information on trending of activities and changes occurring in the region. Be sure to keep up-to-date on Who’s Who in China. This report will help ensure you’re current, and have a solid understanding of this dynamic, rapidly changing market.
By the Numbers:
- Lists the key 123 Chinese-owned biopharmaceutical organizations
- 81 are recombinant and protein therapeutic biopharmaceutical companies
- 42 are vaccines and blood products manufacturers
Our ranking of the Top 60 organizations is done using our proprietary profile analysis and assessment process. Over 300 pages profiling:
- Company Overview and History
- Senior Managers' Overview
- Ownership and Subsidiaries
- Manufacturing Information
- International GMP Certifications
- Technological and Regulatory Aspects
- International Partnering Objectives
Unique and hard-to-find primary information profiles business focus, and partnering strategies. Stay current on trends, changes, and "Who's Who" in China. Ensure you have got a solid understanding of this dynamic, rapidly changing market.
For more information visit http://www.researchandmarkets.com/research/e90995/directory_of_top_6
Research and Markets
Laura Wood, Senior Manager, press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
